Medical Industry Today
SEE OTHER BRANDS

Bringing you the latest news on healthcare and wellness

Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on July 23, 2025

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports

EXTON, PA, July 23, 2025 (GLOBE NEWSWIRE) -- Biologic use in systemic lupus erythematosus (SLE) is steadily rising, with U.S. rheumatologists now treating close to 40% of their moderate-to-severe patients with biologics. Most expect this number to increase …

Harris Dental Provides Flexible Payment Solutions for New and Existing Patients

Harris Dental Provides Flexible Payment Solutions for New and Existing Patients

Harris Dental Makes Quality Care Accessible with Flexible Payment Options BARNSTABLE, MA, UNITED STATES, July 22, 2025 /⁨EINPresswire.com⁩/ -- Harris Dental is pleased to announce the expansion of its flexible payment solutions, designed to make dental …

Healthcare Heroes PLLC is launching a nationwide wellness certification initiative.

Healthcare Heroes PLLC is launching a nationwide wellness certification initiative.

FRISCO, TX, July 23, 2025 (GLOBE NEWSWIRE) -- Healthcare Heroes PLLC, a wellness-focused organization based in Texas, has announced the launch of a nationwide certification initiative designed to shift modern wellness practices from reactive care to …

Xin Weisheng and Nandani Medical Laboratories Collaborate to Advance Intelligent Pharma Quality in India

Xin Weisheng and Nandani Medical Laboratories Collaborate to Advance Intelligent Pharma Quality in India

Strategic collaboration reflects shared commitment to global pharmaceutical excellence and advanced automation. NEW DELHI, INDIA, UNITED KINGDOM, July 23, 2025 /⁨EINPresswire.com⁩/ -- Strategic collaboration reflects shared commitment to global …

WellSpan officials celebrate progress in construction of 3 WellSpan hospitals

WellSpan officials celebrate progress in construction of 3 WellSpan hospitals

York, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- The construction of three WellSpan hospitals has reached a significant milestone, with the final beams going up as the buildout of these innovative hospitals in central Pennsylvania enters its final stages. …

CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc.

CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc.

CALABASAS, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- In a press release issued earlier today by NeOnc Technologies Holdings, Inc. under the headline, "NeOnc Technologies’ Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com …

Paralyzed Veterans of America Discusses 35th Anniversary of Americans with Disabilities Act (ADA) with YourUpdateTV

Paralyzed Veterans of America Discusses 35th Anniversary of Americans with Disabilities Act (ADA) with YourUpdateTV

Carl Blake, CEO of Paralyzed Veterans of America, conducts nationwide media tour in conjunction with D S Simon Media and YourUpdateTV to discuss the importance of this anniversary, efforts to address disability-related barriers, PVA’s new “Barriers Still …

NBME awarding fee assistance to more than 500 students this summer

NBME awarding fee assistance to more than 500 students this summer

PHILADELPHIA, July 23, 2025 (GLOBE NEWSWIRE) -- As part of its commitment to provide $1 million in funding for medical students with financial need, NBME is accepting applications for its next cycle of the fee assistance program until Aug. 24, 2025. NBME’s …

AscellaHealth Service and Infrastructure Enhancements Support Specialty Drug Manufacturers to Protect Market Share Across Brand, Biosimilar and Generic Launches

AscellaHealth Service and Infrastructure Enhancements Support Specialty Drug Manufacturers to Protect Market Share Across Brand, Biosimilar and Generic Launches

BERWYN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces service and infrastructure enhancements designed to help specialty and rare disease …

Unlocking Growth in the Consumer Packaged Goods Market: What’s Driving the 2030 Surge

Unlocking Growth in the Consumer Packaged Goods Market: What’s Driving the 2030 Surge

Delray Beach, FL, July 23, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the consumer packaged goods (CPG) market size is on a steady growth path, projected to rise from USD 3,450.12 billion in 2025 to USD 4,235.01 billion by 2030, growing at a …

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read Sequencing Project, which will involve …

Inotrem Unveils Game-Changing Precision Medicine Strategy for Nangibotide Clinical Development in Septic Shock

Inotrem Unveils Game-Changing Precision Medicine Strategy for Nangibotide Clinical Development in Septic Shock

Inotrem Unveils Game-Changing Precision Medicine Strategy for Nangibotide Clinical Development in Septic Shock Published in Intensive Care Medicine, Inotrem’s results highlight the pivotal role of the soluble TREM-1 biomarker in identifying high-risk …

Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore Immune Function in the Elderly

Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore Immune Function in the Elderly

VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is …

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major …

NeOnc Technologies’ Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks — Today at 11:00 a.m. ET

NeOnc Technologies’ Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks — Today at 11:00 a.m. ET

CALABASAS, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI), a clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, is pleased to announce that its …

Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company

Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company

BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”) today announced the appointment of Kristin Yarema, Ph.D. as Chief Executive Officer of ImageneBio (“Imagene …

Akari Therapeutics Continues Key Research on its Novel Antibody Drug Conjugate Payload PH1 to Further Demonstrate its Unique Ability to Target Cancers Fueled by Oncogenic Drivers

Akari Therapeutics Continues Key Research on its Novel Antibody Drug Conjugate Payload PH1 to Further Demonstrate its Unique Ability to Target Cancers Fueled by Oncogenic Drivers

PH1 modulates RNA splicing, causing cancer cell death while activating the immune system to attack cancer throughout the body Company advancing pipeline of ADCs using PH1 payload across both Trop2 and an undisclosed target Emerging new preclinical data on …

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Vancouver, Canada, July 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer

Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer

SOUTH SAN FRANCISCO, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Tenvie Therapeutics, a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases, today announced the appointment of Tony Estrada, Ph. …

Windward Bio Initiates Global Phase 2 Asthma Trial of WIN378, a Potential Best-in-Disease, Long-Acting, Anti-TSLP Monoclonal Antibody

Windward Bio Initiates Global Phase 2 Asthma Trial of WIN378, a Potential Best-in-Disease, Long-Acting, Anti-TSLP Monoclonal Antibody

Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of WIN378 in patients with asthma, with a first data readout expected in mid-2026 WIN378 has the potential to be the first-to-market long-acting, anti-TSLP antibody with twice-yearly …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions